ARTICLE | Clinical News
Transgenic antithrombin III: GZTC began Phase I testing in the U.K.
September 9, 1996 7:00 AM UTC
Genzyme Transgenics Corp. (GZTC), Framingham, Mass. Product: Transgenic antithrombin III (ATIII) from goat’s milk Indication: Prevent clots in acquired or inherited ATIII deficiencies Status: GZTC b...